Expertise in
3
conditions

Sophie Auriacombe

Bordeaux, FR 
Expertise in
3
conditions
Bordeaux, FR 

Overview

Sophie Auriacombe practices practicing medicine in Bordeaux, France.

Ms. Auriacombe is highly rated in 3 conditions, according to our data. Her clinical expertise encompasses Dementia, Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Primary Lateral Sclerosis, and Frontotemporal Dementia.

She is actively involved in clinical research, co-authoring 33 peer reviewed articles and participating in 2 clinical trials.

Gender

Female

Locations

Bordeaux, France
Other Locations
Dijon, France
Lyon, France
Paris, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Efficacy, Safety and Biomarker Effects of ALZ-801 in Subjects With Early Alzheimer's Disease and APOE4/4 Genotype
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Efficacy, Safety and Biomarker Effects of ALZ-801 in Subjects With Early Alzheimer's Disease and APOE4/4 Genotype
Enrollment Status: Completed
Publish Date: November 10, 2025
Intervention Type: Drug
Study Drug: ALZ-801
Study Phase: Phase 3
A Phase 3 Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Aducanumab (BIIB037) in Subjects With Early Alzheimer's Disease
A Phase 3 Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Aducanumab (BIIB037) in Subjects With Early Alzheimer's Disease
Enrollment Status: Terminated
Publish Date: September 02, 2021
Intervention Type: Drug
Study Phase: Phase 3
View 1 Less Clinical Trial

32 Total Publications

Design and baseline findings of the NEODEM prospective cohort on early-onset neurodegenerative dementia.
Design and baseline findings of the NEODEM prospective cohort on early-onset neurodegenerative dementia.
Journal: Alzheimer's & dementia (Amsterdam, Netherlands)
Published: January 25, 2026

Frequently Asked Questions about Sophie Auriacombe

Is Sophie Auriacombe a top-rated expert for Dementia?

MediFind is an objective health platform that identifies experts based on real-world data. Sophie Auriacombe is classified as an Advanced expert for Dementia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Sophie Auriacombe participate in research or clinical trials?

Yes. Sophie Auriacombe has published 32 articles and abstracts on conditions like Dementia. You can view a list of Sophie Auriacombe's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Auriacombe's expertise for a condition
ConditionClose
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile